MMS Acquires Exploristics

February 20, 2025

MMS, a data-focused clinical research organization (CRO), has acquired Exploristics, a Belfast-based biostatistics and data-science firm. The deal adds Exploristics' KerusCloud study simulation platform and strengthens MMS's biometrics, statistical design, and global clinical trial capabilities.

Buyers
MMS
Targets
Exploristics
Location
Northern Ireland, United Kingdom
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.